---
title: "Castle Biosciences Inc. to Announce Third Quarter 2025 Financial Results"
description: "Castle Biosciences Inc. will announce its third quarter 2025 financial results on November 3, 2025, after market close. A conference call and webcast will follow at 4:30 p.m. Eastern time. The results"
type: "news"
locale: "en"
url: "https://longbridge.com/en/news/260882387.md"
published_at: "2025-10-13T11:00:18.000Z"
---

# Castle Biosciences Inc. to Announce Third Quarter 2025 Financial Results

> Castle Biosciences Inc. will announce its third quarter 2025 financial results on November 3, 2025, after market close. A conference call and webcast will follow at 4:30 p.m. Eastern time. The results will be available on the company's Investor Relations page, and the live webcast can be accessed there as well.

Castle Biosciences Inc. will release its third quarter 2025 financial results on Monday, Nov. 3, 2025, after the close of market. Company management will host a conference call and webcast to discuss the results at 4:30 p.m. Eastern time on the same day. The results will be available on the Investor Relations page of the Company’s website: Investor Relations page of the Company’s website (here). The live webcast can be accessed at here Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Castle Biosciences Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: GNW9543157-en) on October 13, 2025, and is solely responsible for the information contained therein. © Copyright 2025 - Public Technologies (PUBT)

### Related Stocks

- [CSTL.US - Castle Biosciences](https://longbridge.com/en/quote/CSTL.US.md)

## Related News & Research

| Title | Description | URL |
|-------|-------------|-----|
| Castle Biosciences CEO Derek J. Maetzold Reports Sale of Common Shares | Castle Biosciences CEO Derek J. Maetzold has reported the sale of common shares of the company. The full filing is avail | [Link](https://longbridge.com/en/news/271837247.md) |
| Castle Biosciences CEO Derek J. Maetzold Reports Sale of Common Shares | Derek J. Maetzold, CEO of Castle Biosciences Inc., reported the sale of common shares of the company. The full filing is | [Link](https://longbridge.com/en/news/271030149.md) |
| Knight-Swift Transportation Holdings Inc. raises dividend by 11.1% to $0.20 | Knight-Swift Transportation Holdings Inc. raises dividend by 11.1% to $0.20 | [Link](https://longbridge.com/en/news/275769275.md) |
| Cibc World Market Inc. Invests $1.22 Million in QXO, Inc. $QXO | Cibc World Market Inc. has invested $1.22 million in QXO, Inc. by acquiring 64,153 shares during Q3, as reported in its  | [Link](https://longbridge.com/en/news/276106337.md) |
| JANA Partners Management LP Disposes of Mercury Systems Inc. Common Shares | JANA Partners Management, LP has disposed of its common shares in Mercury Systems Inc. The full filing is available thro | [Link](https://longbridge.com/en/news/275690743.md) |

---

> **Disclaimer**: This article is for reference only and does not constitute any investment advice.